Newron Pharma To Present At The Jefferies 2016 Healthcare Conference In New York

MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) [Ticker: SIX: NWRN], a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today announced that Stefan Weber, CEO, will present at the Jefferies 2016 Healthcare Conference in New York, NY on Tuesday, June 7, 2016 at 3:00 p.m. ET.

Back to news